When a 2017 “What‑If” Finally Got Its Moment in the Age of GenAI

A Chance Meeting That Sparked a Crazy Idea

In 2017, a chance meeting with a marketeer drew me to an interesting problem.

All of pharma's marketing assets are heavily regulated. Every promotional asset would undergo a rigorous 5- 10 week process called as MLR (Medical Legal Review).

This would bring in the creative agency, brand teams, medical and legal review teams on one proverbial table. They would apply their understanding of FDA Fair Balance guidelines.

Fair balance, at its core, requires that risks be given prominence and readability comparable to benefits.

That moment planted the seed of an idea that would sit in my mind for eight years:

A compliance‑first portal that could ingest a creative asset, break it down, score it against FDA rules, and hand back concrete, actionable feedback in seconds.

Great ideas don’t die because they’re bad; they die because the ecosystem isn’t ready

In 2017 the technology simply wasn’t there. I could extract text from a PDF with a quick Python script, but I couldn’t “understand” the nuance of a claim, spot subtle risk‑benefit trade‑offs, content placement, or generate a human‑readable justification for a score.

I also did the product-market fit analysis, and it wasn't looking pretty.

Long story short. It was an extremely clever idea but the technology wasn't ready, regulatory enforcement wasn't there, and the companies had no incentive to change the status quo.

So the idea stayed on the back burner while I chased other priorities. The graveyard of “ahead‑of‑its‑time” concepts is surprisingly large—my own included.

Fast‑Forward to 2026 – Why the Moment Is Finally Here

Fast forward eight years, and three seismic shifts have turned my dormant thought experiment into a **real‑world opportunity**:

• **Generative AI & Agentic Systems Are No Longer Demo‑Only** – LLMs now write code, design slides, generate video, and even build interactive 3D worlds. Tools like Google’s [**Genie**](https://labs.google/projectgenie) can spin up fully fledged virtual environments in minutes.
• **Regulatory Heat Is Turning Up** – In 2025 the FDA’s Office of Prescription Drug Promotion (OPDP) issued **73 warning letters** to traditional manufacturers in a single quarter, with **over 100 letters in one day** (see [FDA crackdown](https://www.fda.gov/news-events/press-announcements/fda-launches-crackdown-deceptive-drug-advertising)). The focus has moved from “fair balance” to **Clear, Conspicuous, and Neutral (CCN)**—a stricter, comprehension‑first standard.
• **Leadership FOMO Is Real** – Pharma leaders are demanding **60%+faster processes** and **50%+ cost cuts**. The willingness to experiment with generative AI is no longer a novelty; it’s a board‑room imperative.

The New Blueprint – How a GenAI/ AgenticAI Powered Marketing Promotional Compliance Portal Will Work

Imagine a cloud‑native portal where a creative team drags a draft promotional asset (PDF, PowerPoint, video storyboard, etc.) into a upload zone. Here’s what happens behind the scenes:

Here is how this process could work for this sample print ad:

**Disclaimer:** The following content represents a simulated GenAI evaluation flow. Any draft recommendations generated herein are for informational purposes and do not represent a final compliance verdict or a formal finding of non-compliance.

Call to Action – Let’s Build the Future of Pharma Compliance Together

The idea that kept me up at night in 2017 finally has a runway. While the illustration above was for a static print ad, we now have the capabilities to analyze promotional materials across all modalities (video, web banners, ads etc.)

The question now isn’t *if* we can build it, but *how quickly* we can turn it from prototype to production at scale.

**If you’re a pharma marketer, agency partner, or MLR process owner who’s tired of long and manual MLR cycles, I’d love to hear from you.**

Drop a comment below with the biggest bottleneck you face today, or message me directly to explore a pilot collaboration.

Together we can transform a process that has held the industry back for decades into a **speed‑driven, data‑rich, compliance‑first engine**—exactly the kind of “smart pacing” I wrote about in [*The Human Factor – Why Big Ideas Need Smart Pacing.*](https://www.linkedin.com/pulse/human-factor-why-big-tech-ideas-need-smart-pacing-lessons-upadhyay-ilohc/?trackingId=4wLjnUjuQXW6VpocxCo%2FTw%3D%3D)

#PharmaCompliance #GenerativeAI #MLR #RegTech #DigitalTransformation #Leadership #Innovation